SEC Filing Summary

Marcio Souza, Chief Executive Officer and Director of Praxis Precision Medicines, Inc., reported a disposition of 20,521 shares of Common Stock on July 8, 2026, valued at $0.00. The transaction, coded as a gift (G), resulted in 56,495 shares held directly post-transaction. Additionally, 2,600 shares held indirectly were disposed of, also valued at $0.00. This disposition is noted as a bona fide gift to the Souza 2026 Trust. The filing was made on Form 4, with the signature executed by Alex Nemiroff as Attorney-in-Fact.